This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cov-2 | 1315 |
respiratory | syndrome | 609 |
covid-19 | patients | 382 |
severe | cases | 205 |
immune | response | 202 |
respiratory | failure | 200 |
severe | disease | 185 |
severe | malaria | 180 |
renal | failure | 153 |
inflammatory | response | 127 |
immune | responses | 119 |
severe | covid-19 | 101 |
severe | group | 98 |
severe | patients | 96 |
chronic | liver | 95 |
viral | infections | 88 |
- | cell | 83 |
respiratory | disease | 82 |
viral | infection | 75 |
covid-19 | cases | 72 |
acute | liver | 69 |
covid-19 | infection | 68 |
high | risk | 57 |
acute | lung | 53 |
higher | risk | 52 |
immune | cells | 48 |
respiratory | viruses | 47 |
- | infection | 47 |
high | levels | 46 |
present | study | 44 |
pulmonary | disease | 41 |
inflammatory | responses | 39 |
severe | liver | 39 |
- | risk | 37 |
clinical | studies | 33 |
severe | infection | 33 |
- | sars | 31 |
- | coronavirus | 28 |
mild | cases | 28 |
respiratory | infections | 28 |
higher | levels | 27 |
severe | infections | 25 |
human | coronavirus | 24 |
other | factors | 24 |
mild | patients | 22 |
severe | sars | 22 |
high | level | 20 |
- | infections | 19 |
severe | lung | 18 |
such | patients | 18 |
- | level | 17 |
- | protein | 17 |
important | factor | 17 |
low | levels | 16 |
renal | disease | 16 |
- | cells | 16 |
covid-19 | disease | 16 |
human | disease | 15 |
human | infection | 15 |
inflammatory | diseases | 15 |
inflammatory | syndrome | 15 |
chronic | lung | 15 |
other | diseases | 14 |
respiratory | infection | 14 |
renal | blood | 14 |
significant | risk | 14 |
inflammatory | cells | 14 |
first | case | 14 |
- | effects | 14 |
inflammatory | cell | 14 |
clinical | disease | 13 |
clinical | treatment | 13 |
severe | coronavirus | 13 |
such | cases | 13 |
mild | covid-19 | 12 |
viral | proteins | 12 |
other | studies | 12 |
clinical | study | 12 |
lower | levels | 12 |
immune | cell | 12 |
respiratory | diseases | 11 |
mild | disease | 11 |
other | patients | 11 |
common | patients | 11 |
inflammatory | drugs | 11 |
- | factor | 11 |
clinical | syndromes | 10 |
early | treatment | 10 |
high | blood | 10 |
human | lung | 10 |
other | drugs | 10 |
other | viruses | 10 |
pulmonary | infection | 10 |
specific | treatment | 10 |
clinical | case | 9 |
viral | diseases | 9 |
clinical | response | 9 |
acute | malaria | 9 |
acute | sars | 9 |
- | group | 9 |
more | patients | 8 |
viral | protein | 8 |
viral | disease | 8 |
severe | patient | 8 |
respiratory | virus | 8 |
other | cases | 8 |
normal | blood | 8 |
low | risk | 8 |
human | cases | 8 |
first | day | 8 |
first | cases | 8 |
covid-19 | patient | 8 |
acute | infection | 8 |
- | drug | 8 |
inflammatory | factors | 8 |
normal | lung | 7 |
important | factors | 7 |
viral | drugs | 7 |
specific | cell | 7 |
severe | case | 7 |
pulmonary | infections | 7 |
other | sars | 7 |
human | diseases | 7 |
human | sars | 7 |
different | groups | 7 |
clinical | syndrome | 7 |
chronic | infection | 7 |
acute | covid-19 | 7 |
- | virus | 7 |
respiratory | covid-19 | 6 |
small | blood | 6 |
small | cell | 6 |
human | blood | 6 |
specific | infections | 6 |
specific | therapies | 6 |
viral | responses | 6 |
presenting | cells | 6 |
pulmonary | blood | 6 |
- | day | 6 |
other | coronavirus | 6 |
other | cell | 6 |
normal | liver | 6 |
normal | levels | 6 |
low | level | 6 |
early | response | 6 |
different | cell | 6 |
clinical | cases | 6 |
respiratory | coronavirus | 5 |
other | proteins | 5 |
other | treatment | 5 |
other | treatments | 5 |
more | cases | 5 |
severe | groups | 5 |
significant | effect | 5 |
such | infections | 5 |
such | studies | 5 |
lower | risk | 5 |
mild | group | 5 |
human | malaria | 5 |
inflammatory | protein | 5 |
different | disease | 5 |
- | factors | 5 |
chronic | disease | 5 |
chronic | infections | 5 |
clinical | therapies | 5 |
inflammatory | effects | 5 |
different | treatment | 5 |
human | lungs | 5 |
- | case | 5 |
important | risk | 5 |
first | days | 4 |
specific | therapy | 4 |
pulmonary | syndrome | 4 |
other | risk | 4 |
other | groups | 4 |
other | cells | 4 |
normal | level | 4 |
lower | level | 4 |
inflammatory | disease | 4 |
higher | level | 4 |
viral | factors | 4 |
early | sars | 4 |
different | studies | 4 |
covid-19 | treatment | 4 |
common | virus | 4 |
clinical | risk | 4 |
chronic | therapy | 4 |
- | treatment | 4 |
- | study | 4 |
- | effect | 4 |
- | blood | 4 |
different | levels | 4 |
mild | sars | 3 |
normal | lungs | 3 |
more | studies | 3 |
other | day | 3 |
human | studies | 3 |
mild | liver | 3 |
low | blood | 3 |
inflammatory | treatments | 3 |
inflammatory | lung | 3 |
normal | response | 3 |
human | cell | 3 |
other | disease | 3 |
other | patient | 3 |
pulmonary | diseases | 3 |
pulmonary | response | 3 |
severe | treatment | 3 |
small | children | 3 |
small | studies | 3 |
small | study | 3 |
specific | sars | 3 |
viral | therapies | 3 |
human | protein | 3 |
severe | diseases | 3 |
human | case | 3 |
covid-19 | lung | 3 |
highest | risk | 3 |
- | disease | 3 |
- | groups | 3 |
- | patient | 3 |
- | patients | 3 |
acute | disease | 3 |
acute | infections | 3 |
clinical | effects | 3 |
common | risk | 3 |
covid-19 | infections | 3 |
- | response | 3 |
covid-19 | therapies | 3 |
different | treatments | 3 |
early | infection | 3 |
early | risk | 3 |
early | studies | 3 |
first | drug | 3 |
high | protein | 3 |
high | virus | 3 |
highest | levels | 3 |
different | patient | 3 |
low | factor | 2 |
more | days | 2 |
milder | disease | 2 |
mild | infections | 2 |
mild | infection | 2 |
lower | lung | 2 |
human | covid-19 | 2 |
inflammatory | effect | 2 |
immune | patients | 2 |
immune | factors | 2 |
human | response | 2 |
other | infections | 2 |
more | disease | 2 |
viral | response | 2 |
other | lung | 2 |
other | therapies | 2 |
other | virus | 2 |
renal | cell | 2 |
respiratory | cells | 2 |
significant | liver | 2 |
specific | proteins | 2 |
specific | viruses | 2 |
such | study | 2 |
such | treatment | 2 |
highest | level | 2 |
viral | therapy | 2 |
human | cells | 2 |
mild | case | 2 |
higher | case | 2 |
covid-19 | case | 2 |
high | treatment | 2 |
- | covid-19 | 2 |
- | therapy | 2 |
acute | cases | 2 |
acute | response | 2 |
chronic | diseases | 2 |
clinical | effect | 2 |
clinical | liver | 2 |
clinical | malaria | 2 |
common | coronavirus | 2 |
common | disease | 2 |
common | viruses | 2 |
chronic | blood | 2 |
covid-19 | risk | 2 |
earlier | studies | 2 |
high | malaria | 2 |
covid-19 | treatments | 2 |
first | group | 2 |
first | covid-19 | 2 |
early | case | 2 |
early | cases | 2 |
different | sars | 2 |
different | proteins | 2 |
different | patients | 2 |
different | drug | 2 |
other | protein | 1 |
other | liver | 1 |
pulmonary | cells | 1 |
other | study | 1 |
others | risk | 1 |
presented | case | 1 |
presented | disease | 1 |
presented | patients | 1 |
presented | sars | 1 |
pulmonary | malaria | 1 |
pulmonary | effects | 1 |
pulmonary | failure | 1 |
pulmonary | group | 1 |
pulmonary | level | 1 |
pulmonary | patients | 1 |
renal | diseases | 1 |
other | effects | 1 |
renal | response | 1 |
other | group | 1 |
lowest | risk | 1 |
other | blood | 1 |
mild | lung | 1 |
respiratory | cases | 1 |
low | liver | 1 |
low | lung | 1 |
low | patient | 1 |
low | protein | 1 |
low | sars | 1 |
low | treatment | 1 |
lower | liver | 1 |
more | case | 1 |
normal | protein | 1 |
more | children | 1 |
more | effect | 1 |
more | risk | 1 |
more | treatment | 1 |
more | treatments | 1 |
non | protein | 1 |
normal | child | 1 |
normal | children | 1 |
renal | syndrome | 1 |
viral | drug | 1 |
respiratory | factors | 1 |
specific | responses | 1 |
specific | drugs | 1 |
specific | factor | 1 |
specific | factors | 1 |
specific | groups | 1 |
specific | infection | 1 |
specific | patient | 1 |
specific | protein | 1 |
specific | response | 1 |
specific | risk | 1 |
respiratory | response | 1 |
such | cells | 1 |
such | risk | 1 |
such | risks | 1 |
such | therapies | 1 |
low | % | 1 |
viral | effects | 1 |
viral | factor | 1 |
viral | lung | 1 |
specific | drug | 1 |
smaller | case | 1 |
small | proteins | 1 |
small | patients | 1 |
respiratory | therapy | 1 |
severe | blood | 1 |
severe | drug | 1 |
severe | responses | 1 |
severe | syndromes | 1 |
severe | therapy | 1 |
significant | blood | 1 |
significant | factors | 1 |
significant | failure | 1 |
significant | infection | 1 |
significant | infections | 1 |
significant | level | 1 |
significant | lung | 1 |
significant | risks | 1 |
small | case | 1 |
small | groups | 1 |
small | patient | 1 |
low | drug | 1 |
early | blood | 1 |
inflammatory | treatment | 1 |
covid-19 | study | 1 |
common | effects | 1 |
common | factor | 1 |
common | group | 1 |
common | liver | 1 |
common | lung | 1 |
common | study | 1 |
common | syndromes | 1 |
covid-19 | drugs | 1 |
different | blood | 1 |
inflammatory | factor | 1 |
different | case | 1 |
different | coronavirus | 1 |
different | diseases | 1 |
different | effects | 1 |
different | liver | 1 |
different | lung | 1 |
different | responses | 1 |
different | risk | 1 |
common | cells | 1 |
clinical | treatments | 1 |
clinical | sars | 1 |
clinical | responses | 1 |
- | cases | 1 |
- | child | 1 |
- | failure | 1 |
- | levels | 1 |
- | liver | 1 |
- | malaria | 1 |
- | syndrome | 1 |
acute | effects | 1 |
acute | syndrome | 1 |
acute | therapy | 1 |
acute | treatment | 1 |
chronic | effects | 1 |
chronic | failures | 1 |
chronic | patients | 1 |
chronic | treatment | 1 |
clinical | factors | 1 |
clinical | infections | 1 |
different | risks | 1 |
different | study | 1 |
different | virus | 1 |
higher | protein | 1 |
highest | infection | 1 |
human | patients | 1 |
human | study | 1 |
human | virus | 1 |
humans | risk | 1 |
immune | children | 1 |
immune | effects | 1 |
immune | therapies | 1 |
immune | therapy | 1 |
important | cell | 1 |
important | diseases | 1 |
important | effects | 1 |
important | group | 1 |
important | proteins | 1 |
important | response | 1 |
important | therapies | 1 |
inflammatory | drug | 1 |
higher | risks | 1 |
higher | patient | 1 |
earlier | sars | 1 |
higher | infection | 1 |
earlier | study | 1 |
earliest | sars | 1 |
early | disease | 1 |
early | liver | 1 |
early | study | 1 |
early | therapy | 1 |
first | coronavirus | 1 |
first | disease | 1 |
first | drugs | 1 |
first | infection | 1 |
first | response | 1 |
high | case | 1 |
high | disease | 1 |
high | drug | 1 |
high | risks | 1 |
higher | covid-19 | 1 |
higher | drug | 1 |
viral | studies | 1 |